ArticleCureus2026

Durability Benchmarking of Contemporary Second-Line and Later Therapies for Relapsed or Refractory Follicular Lymphoma Using Reconstructed Individual Patient Data From Published Kaplan-Meier Curves.

Oscar J Burke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.